摘要
目的探讨美洛昔康治疗慢性前列腺炎的临床疗效。方法采用随机分组应用美洛昔康治疗慢性前列腺炎组43例,并以未用美洛昔康治疗组42例作对照。按照美国国立卫生研究院慢性前列腺炎症状评分(NIH-CPSI)评估疗效。结果美洛昔康组总有效率82.50%,对照组总有效率65.85%,治疗组治愈、显效、总有效率均高于对照组(P<0.05)。结论美洛昔康治疗慢性前列腺炎的临床疗效优于对照组,其治疗慢性前列腺炎安全而有效。
Objective To evaluate the clinical efficacy of meloxicam in the treatment of chronic prostatitis（CP）. Methods A randomized clinical trial was conducted. The study group included 43 patients who received meloxicam for 8 weeks,and the control group included 42 patients who received no meloxicam. They were classified and evaluated according to the NIH-CPSI. Results The total curative rates of the study and control groups were 82.50% and 65.85%, respectively（P〈0.05）. The curative rate,obvious efficiency rate and total curative rate of the study group were higher than those of the control group（P〈0.05）. Conclusion The clinical efficiency of melocicam is better than the clinical efficiency of the drug used in the control group,and meanwhile,it is effective and safe in the treatment of chronic protatitis.
出处
《中国现代医生》
2010年第2期54-55,共2页
China Modern Doctor
